Neuroendocrinology 2017 Apr 13
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.
Related Questions
New answer by Medical Oncologist at University of Iowa Carver College of Medicine (May 7, 2020)
Unfortunately there is no safety data for the use of PRRT in patients with GFR <30 ml/min. A creatinine clearance <50 ml/min is listed only as a relative contraindicatio...